Microbot Medical (MBOT) Shares Outstanding (Diluted Average) (2022 - 2026)

Microbot Medical (MBOT) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $67.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 116.04% year-over-year to $67.2 million; the trailing twelve-month figure through Mar 2026 stood at $67.2 million (up 116.04% YoY), and the FY2025 full-year result was $45.8 million, up 192.69% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $67.2 million, up from $45.8 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $67.2 million in Q1 2026 and bottomed at $7.1 million in Q2 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $14.3 million (2024), against an average of $21.0 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) gained 29.41%; it then jumped 192.69% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $7.3 million in 2022, then surged by 40.49% to $10.2 million in 2023, then jumped by 53.38% to $15.6 million in 2024, then soared by 192.69% to $45.8 million in 2025, then surged by 46.66% to $67.2 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $67.2 million (Q1 2026), $45.8 million (Q4 2025), and $38.6 million (Q3 2025), per Business Quant data.

Peer Comparison